Bryan Giraudo
COO/CFO; Director · 3 filings · Latest: Aug 24, 2026
Gossamer Bio, Inc.
Protagonist Therapeutics, Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PTGX | Bryan Giraudo | Director | May 8, 2026 | Sale | $100.00 | 11,130 | $1.1M | 12,695 | |
PTGX | Bryan Giraudo | Director | May 7, 2026 | Sale | $100.12 | 48,000 | $4.8M | 6,000 | |
PTGX | Bryan Giraudo | Director | May 7, 2026 | Option Exercise | $6.63 | 36,000 | $238.6K | 43,825 | |
PTGX | BRYAN M & COURTNEY L GIRAUDO RT | — | May 8, 2026 | Proposed Sale | $100.00 | 11,130 | $1.1M | — | |
PTGX | BRYAN GIRAUDO | — | May 7, 2026 | Proposed Sale | $100.14 | 36,000 | $3.6M | — | |
PTGX | BRYAN M & COURTNEY L GIRAUDO RT | — | May 7, 2026 | Proposed Sale | $100.07 | 12,000 | $1.2M | — |